Effect of combination therapy (Ang II antagonist, valsartan and a calcium channel blocker) in a hypertensive model of diabetic nephropathy

被引:0
|
作者
Allen, T
Davis, B
de Gasparo, M
Cooper, M
机构
[1] Univ Melbourne, Dept Med, Heidelberg, Vic, Australia
[2] Novartis Pharmaceut, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S137 / S137
页数:1
相关论文
共 50 条
  • [1] Combination of direct rennin inhibitor - aliskiren, angiotensin II receptor blocker - valsartan, and calcium channel blocker - amlodipine, in therapy of hypertensive patient with gout (case report)
    Dralova, O. V.
    Maksimov, M. L.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (04) : 468 - 472
  • [2] Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients
    Doi, Masayuki
    Miyoshi, Toru
    Hirohata, Satoshi
    Kamikawa, Shigeshi
    Usui, Shinichi
    Kaji, Youko
    Sakane, Kosuke
    Ogawa, Hiroko
    Ninomiya, Yoshifumi
    Kusachi, Shozo
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (05): : 433 - 439
  • [3] Effect of calcium channel blocker in experimentally induced diabetic nephropathy in rats
    Yousef, W. M.
    Morsy, M. D.
    El-Wahed, M. M. Abd
    Ghanayem, N. M.
    Omar, A. H.
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S201 - S201
  • [4] The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: The OLCA study
    Daikuhara, Hiroyuki
    Kikuchi, Fumi
    Ishida, Toshihiko
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (04): : 280 - 286
  • [5] Renoprotective effect of a calcium channel blocker, benidipine, in combination with an angiotensin II receptor blocker in hypertensive patients with chronic kidney disease
    Dohi, Y.
    Miyagawa, K.
    Nakazawa, A.
    Kimura, G.
    JOURNAL OF HYPERTENSION, 2008, 26 : S515 - S515
  • [6] Effects of Exercise Therapy Alone and in Combination with a Calcium Channel Blocker or an Angiotensin Receptor Blocker in Hypertensive Patients
    Ohta, Masanori
    Tajiri, Yuji
    Yamato, Hiroshi
    Ikeda, Masaharu
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2012, 34 (07) : 523 - 529
  • [7] Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy
    Hebert, LA
    Falkenhain, ME
    Nahman, NS
    Cosio, FG
    O'Dorisio, TM
    AMERICAN JOURNAL OF NEPHROLOGY, 1999, 19 (01) : 1 - 6
  • [8] The calcium channel blocker controversy in patients with diabetic nephropathy: Is there an issue?
    Ruilope L.M.
    Campo C.
    Segura J.
    Current Hypertension Reports, 2001, 3 (5) : 419 - 421
  • [9] Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease
    Ishimitsu, Toshihiko
    Ohno, Eri
    Nakano, Nobuyuki
    Furukata, Satoshi
    Akashiba, Akira
    Minami, Junichi
    Numabe, Atsushi
    Matsuoka, Hiroaki
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2011, 33 (06) : 366 - 372
  • [10] Calcium Channel Blocker Therapy in Black Hypertensive Patients
    Brewster, Lizzy M.
    van Montfrans, Gert A.
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (03) : 218 - 218